Clinical and functional long-term outcome of patients at clinical high risk (CHR) for psychosis without transition to psychosis: A systematic review

被引:65
作者
Beck, Katharina [1 ,2 ]
Andreou, Christina [1 ]
Studerus, Erich [1 ]
Heitz, Ulrike [1 ,2 ]
Ittig, Sarah [1 ]
Leanza, Letizia [1 ,2 ]
Riecher-Roessler, Anita [1 ]
机构
[1] Univ Basel, Psychiat Hosp, Ctr Gender Res & Early Detect, Wilhelm Klein Str 27, CH-4002 Basel, Switzerland
[2] Univ Basel, Div Clin Psychol & Epidemiol, Dept Psychol, Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
Prodromal; Non-converters; Non-psychotic disorders; Psychosocial; Remission; ULTRA-HIGH-RISK; MENTAL STATE; EPA GUIDANCE; INDIVIDUALS; SYMPTOMS; RESILIENCE; PREDICTORS; REMISSION; METAANALYSIS; RECOGNITION;
D O I
10.1016/j.schres.2018.12.047
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Research on patients at clinical high risk (CHR) for psychosis has so far mainly focused on those with transition to frank psychosis (CHR-T patients). However, the majority of CHR patients do not transition (CHR-NT patients) and relatively little information is available on their clinical and functional outcome. Methods: We conducted a systematic review on clinical and functional long-term outcome of CHR-NT patients. Studies were included if they had an average follow-up period of at least 24 months and reported on long-term outcome of CHR-NT patients in one or more of the following domains: (non-) remission from CHR, prevalence of clinical symptoms and/or clinical diagnoses (axis I and II), and psychosocial functioning. Results: Ten publications from seven different single or multicenter studies with average follow-up durations of 2-7.5 years could be included. At the last follow-up assessment 28-71% of CHR-NT patients were not remitted from their CHR and 22-82% still had at least one clinical diagnosis. Approximately half of CHR-NT patients presented with poor psychosocial outcome at 2-year and 6-year follow-up. Conclusions: The results suggest that, in the long-term, the majority of CHR-NT patients are not in full clinical remission and seem to suffer from one or more clinical disorders and psychosocial impairments. Since relatively few studies could be identified, further research is required to better understand the trajectories and clinical needs of CHR-NT patients. (C) 2019 Elsevier B.V. All rights reserved.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 64 条
  • [61] Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups
    Woods, Scott W.
    Powers, Albert R., III
    Taylor, Jerome H.
    Davidson, Charlie A.
    Johannesen, Jason K.
    Addington, Jean
    Perkins, Diana O.
    Bearden, Carrie E.
    Cadenhead, Kristin S.
    Cannon, Tyrone D.
    Cornblatt, Barbara A.
    Seidman, Larry J.
    Tsuang, Ming T.
    Walker, Elaine F.
    McGlashan, Thomas H.
    [J]. SCHIZOPHRENIA BULLETIN, 2018, 44 (02) : 254 - 263
  • [62] Public and private psychiatry: can they work together and is it worth the effort?
    Yung, A
    Gill, L
    Sommerville, E
    Dowling, B
    Simon, K
    Pirkis, J
    Livingston, J
    Schweitzer, I
    Tanaghow, A
    Herrman, H
    Trauer, T
    Grigg, M
    Burgess, P
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2005, 39 (1-2) : 67 - 73
  • [63] Treatment of people at ultra-high risk for psychosis
    Yung, Alison R.
    [J]. WORLD PSYCHIATRY, 2017, 16 (02): : 207 - 208
  • [64] Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features
    Yung, AR
    Phillips, LJ
    Yuen, HP
    McGorry, PD
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (2-3) : 131 - 142